Renovaro Biosciences
RENB
#7734
Rank
A$0.41 B
Marketcap
$2.62
Share price
6.15%
Change (1 day)
-45.16%
Change (1 year)

Renovaro Biosciences (RENB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$37.94 Million

According to Renovaro Biosciences's latest financial reports the company's total liabilities are A$37.94 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Renovaro Biosciences - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30A$17.82 M2.08%
2022-06-30A$17.46 M-12.2%
2021-06-30A$19.88 M15.52%
2020-06-30A$17.21 M78.36%
2019-06-30A$9.65 M-69.93%
2018-06-30A$32.1 M725.26%
2017-06-30A$3.88 M92.65%
2016-06-30A$2.01 M
2014-12-31A$2.14 M
2013-03-31A$0.06 M160.68%
2012-03-31A$0.02 M209.95%
2011-03-31A$0 M